Next-generation-sequencing report published

Detailed overview of the landscape of next-generation sequencing technology and its clinical relevance and impact on improving patient care
October 21, 2012

(Credit: Wikimedia Commons)

The Association for Molecular Pathology (AMP) has published the report of the Whole Genome Analysis (WGA) Working Group of the AMP Clinical Practice Committee in the November 2012 issue of The Journal of Molecular Diagnostics (JMD).

Titled Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing, the open-access report provides an overview of the landscape of next generation sequencing (NGS) technology, its clinical relevance, and its impact on improving patient care.

This report illuminates the opportunities and challenges associated with clinical diagnostic genome sequencing. It reviews the rapidly evolving technologies; provides application examples; discuss aspects of clinical utility, ethics, and consent; and addresses the analytic, postanalytic, and professional implications.